Who Makes Tradjenta (linagliptin)?
Tradjenta is manufactured by two pharmaceutical companies: Boehringer Ingelheim and Eli Lilly and Company. They co-developed and co-market Tradgenta (linagliptin) globally. Trade names also include Trajenta, Trazenta, and Trayenta.
Tradjenta Manufacturer Overview
| Trade Name | Tradjenta, Trajenta, Trazenta, Trayenta |
| Manufacturer | Boehringer Ingelheim and Eli Lilly and Company |
| Active Ingredient | Linagliptin |
| Formula | C25H28N8O2 |
| FDA-Approval Date | May 2, 2011 |
| FDA-Approved Uses | Improve glycemic control in adults with type 2 diabetes mellitus |
| Website | https://patient.boehringer-ingelheim.com/us/products/tradjenta/ |
What Does Tradjenta Treat?
Tradjenta is a prescription medication used to control high blood sugar levels in adults with type 2 diabetes. It is not a cure for the condition, but it can help manage blood sugar levels when used alongside diet and exercise.
It’s important to note that Tradjenta should only be taken under the supervision of a healthcare professional and is not suitable for treating other types of diabetes, such as type 1. They can determine if Tradjenta is the right treatment for your specific condition and address any potential risks or side effects.
Explore More Medication Manufacturers
Now that you know more about who makes Tradjenta, the manufacturer details, and what medical conditions it treats, you may want to compare Tradjenta to other medication manufacturers.
Browse the medication maker guides to research popular brands and find information on a specific company.
Who’s Query is an online encyclopedia of product owners and manufacturer information that educates users about who makes popular brands.
